The current HPV vaccine coverage policy adversely affects individuals who did not have the opportunity to receive the vaccine by the age when coverage ends. This includes those who, due to personal circumstances or medical reasons, missed the typical eligibility period. Additionally, the high cost of the HPV vaccine creates a financial barrier, limiting access for many individuals who are at risk of HPV-related health issues.

If the policy remains unchanged, individuals who missed the vaccine during the eligible period will continue to face heightened health risks associated with HPV. The financial barrier created by the high cost of the vaccine further limits access for those who need it most. This situation may lead to increased vulnerability to HPV and related health issues among various groups, including those in the LGBTQIA2S+ community who may also face challenges in accessing adequate protection against STI's.

Addressing these issues now is crucial to ensuring equitable healthcare access. By revising the HPV vaccine policy to include broader eligibility and considering ways to make the vaccine more affordable, we can protect individuals who missed the vaccine during the standard coverage period and reduce financial barriers. Immediate action will help prevent further health disparities and ensure that all individuals have the opportunity to receive this important vaccine, regardless of their circumstances or financial situation.